Journal of the Korean Association of Oral and Maxillofacial Surgeons
- P-ISSN2234-7550
- E-ISSN2234-5930
- SCOPUS, KCI, ESCI
ISSN : 2234-7550
Autologous blood derived cell therapy in maxillofacial bone graft surgery
Journal of the Korean Association of Oral and Maxillofacial Surgeons / Journal of the Korean Association of Oral and Maxillofacial Surgeons, (P)2234-7550; (E)2234-5930
2021, v.47 no.6, pp.480-483
https://doi.org/10.5125/jkaoms.2021.47.6.480
Joo-Young Park (Seoul National University, Seoul, Korea)
Joo-Young,
P.
(2021). Autologous blood derived cell therapy in maxillofacial bone graft surgery. Journal of the Korean Association of Oral and Maxillofacial Surgeons, 47(6), 480-483, https://doi.org/10.5125/jkaoms.2021.47.6.480
Abstract
Tissue regeneration is one of the ultimate goals of maxillofacial surgery and various types of tissue engineering technologies have been utilized in clin-ics. Healthy resources of host cells and growth factors are essential for the tissue engineering, therefore autologous blood-derived cell therapy was in-troduced. In this article, clinical applications of the autologous platelet concentrates and stem cell separation therapy will be summarized and evaluated for their efficacy and feasibility in the current maxillofacial clinics.
- keywords
- Tissue engineering, Regeneration, Maxilla, Mandible, Autografts
- Downloaded
- Viewed
- 0KCI Citations
- 0WOS Citations